Skip to content

Integra LifeSciences IART Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$69M+1,300%
Axogen logo
AxogenAXGN
$368K-24.7%
ITG
Integer HoldingsITGR
$2.84M+143%
Globus Medical logo
Globus MedicalGMED
AbbVie logo
AbbVieABBV
STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's increase (decrease) in prepaid expense and other assets?
Integra LifeSciences (IART) reported increase (decrease) in prepaid expense and other assets of $21.88M in Q1 2026.
How has Integra LifeSciences's increase (decrease) in prepaid expense and other assets changed year-over-year?
Integra LifeSciences's increase (decrease) in prepaid expense and other assets increased by 24.6% year-over-year, from $17.55M to $21.88M.
What is the long-term trend for Integra LifeSciences's increase (decrease) in prepaid expense and other assets?
Over 2 years (2021 to 2023), Integra LifeSciences's increase (decrease) in prepaid expense and other assets has grown at a -64.6% compound annual growth rate (CAGR), from $21.14M to -$2.65M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.